Related references
Note: Only part of the references are listed.Structural and functional basis for increased HDL-cholesterol levels due to the naturally occurring V19L mutation in human apolipoprotein A-I
Christina Gkolfinopoulou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2020)
HDL Dysfunction Caused by Mutations in apoA-I and Other Genes that are Critical for HDL Biogenesis and Remodeling
Angeliki Chroni et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Lipidomics of Bioactive Lipids in Acute Coronary Syndromes
Zahra Solati et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity
Ioannis Dafnis et al.
BIOCHEMICAL JOURNAL (2018)
High-Density Lipoprotein Functionality as a New Pharmacological Target on Cardiovascular Disease: Unifying Mechanism That Explains High-Density Lipoprotein Protection Toward the Progression of Atherosclerosis
Elda Favari et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2018)
Elevating ATP-binding cassette transporter G1 improves re-endothelialization function of endothelial progenitor cells via Lyn/Akt/eNOS in diabetic mice
Ying Shi et al.
FASEB JOURNAL (2018)
A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state
John T. Melchior et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state
John T. Melchior et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
HDL cholesterol: reappraisal of its clinical relevance
Winfried Maerz et al.
CLINICAL RESEARCH IN CARDIOLOGY (2017)
The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific
Ioannis Dafnis et al.
SCIENTIFIC REPORTS (2016)
Lipid-free Apolipoprotein A-I Structure: Insights into HDL Formation and Atherosclerosis Development
Xiaohu Mei et al.
ARCHIVES OF MEDICAL RESEARCH (2015)
HDL-cholesterol and cardiovascular disease: rethinking our approach
Hasan K. Siddiqi et al.
CURRENT OPINION IN CARDIOLOGY (2015)
A Model of Lipid-Free Apolipoprotein A-I Revealed by Iterative Molecular Dynamics Simulation
Xing Zhang et al.
PLOS ONE (2015)
Structural and Functional Analysis of the ApolipoproteinA-I A164S Variant
Jonathan Dalla-Riva et al.
PLOS ONE (2015)
Oxidized HDL Induces Cytotoxic Effects: Implications for Atherogenic Mechanism
Valliyil Sasidharan Soumyarani et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2014)
Endothelial Microparticle-Mediated Transfer of MicroRNA-126 Promotes Vascular Endothelial Cell Repair via SPRED1 and Is Abrogated in Glucose-Damaged Endothelial Microparticles
Felix Jansen et al.
CIRCULATION (2013)
Significance of the hydrophobic residues 225-230 of apoA-I for the biogenesis of HDL
Panagiotis Fotakis et al.
JOURNAL OF LIPID RESEARCH (2013)
Crystal Structure of Δ(185-243)ApoA-I Suggests a Mechanistic Framework for the Protein Adaptation to the Changing Lipid Load in Good Cholesterol: From Flatland to Sphere land via Double Belt, Belt Buckle, Double Hairpin and Trefoil/Tetrafoil
Olga Gursky
JOURNAL OF MOLECULAR BIOLOGY (2013)
Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux
Georgios Daniil et al.
PLOS ONE (2013)
Novel Biological Functions of High-Density Lipoprotein Cholesterol
Chieko Mineo et al.
CIRCULATION RESEARCH (2012)
Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease
Christian Besler et al.
EMBO MOLECULAR MEDICINE (2012)
Functional Characterization of Newly-Discovered Mutations in Human SR-BI
Alexandra C. Chadwick et al.
PLOS ONE (2012)
Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders
Georgios Daniil et al.
CLINICA CHIMICA ACTA (2011)
Crystal Structure of C-terminal Truncated Apolipoprotein A-I Reveals the Assembly of High Density Lipoprotein (HDL) by Dimerization
Xiaohu Mei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
Christian Besler et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels
C. L. Haase et al.
JOURNAL OF INTERNAL MEDICINE (2011)
Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma
Rong Huang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
A simple approach for human recombinant apolipoprotein E4 expression and purification
Letta Argyri et al.
PROTEIN EXPRESSION AND PURIFICATION (2011)
ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet
Naoki Terasaka et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes
R. A. Gangani D. Silva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-β peptide generation
Woojin Scott Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL
Vassilis I. Zannis et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Structure and stability of apolipoprotein A-I in solution and in discoidal high-density lipoprotein probed by double charge ablation and deletion mutation
IN Gorshkova et al.
BIOCHEMISTRY (2006)
High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I
D Seetharam et al.
CIRCULATION RESEARCH (2006)
Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice
A Chroni et al.
BIOCHEMISTRY (2004)
Probucol inhibits ABCA1-mediated cellular lipid efflux
E Favari et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
A novel ApoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease
GK Hovingh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux -: Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo
A Chroni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Analysis of apolipoprotein A-I, lecithin:cholesterol acyltransferase and glucocerebrosidase genes in hypoalphalipoproteinemia
D Recalde et al.
ATHEROSCLEROSIS (2002)
Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-IZaragoza (L144R)
D Recalde et al.
ATHEROSCLEROSIS (2001)
Probing the lipid-free structure and stability of apolipoprotein A-I by mutation
IN Gorshkova et al.
BIOCHEMISTRY (2000)
The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines
AE Bortnick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
